Background:
Percutaneous vertebroplasty (PVP) is now well accepted in the treatment of painful osteopathic vertebral compression fractures (OVCF), providing early pain relief and strengthening of the bone of the vertebrae. However, some patients still experienced severe back pain after PVP.
Objectives:
To analyze the possible reason for unsatisfactory back pain relief (UBPR) after PVP at early stage.
Study Design:
Retrospective analysis.
Setting:
Hong-Hui Hospital in Xi'an.
Methods:
Between March 2013 and January 2015, a total of 1,316 patients with OVCF were treated by PVP at our Hospital. Demographics, clinical data, and surgical data were collected to analyze the factors associated with UBPR after PVP.
Results:
Sixty cases complained of UBPR, and the prevalence was 4.6%. Univariate analyses showed that preoperative bone mineral density (BMD), number of fractures, cement distribution and volume injected per level, lumbodorsal fascia contusion, and depression were associated with UBPR after PVP (P < 0.001). Multivariate analysis revealed that preoperative BMD (odds ratio [OR], 3.577; P = 0.029), lumbodorsal fascia contusion (OR, 3.805; P = 0.002), number of fractures (OR, 3.440; P < 0.001), cement volume injected per level (OR, 0.079; P < 0.001), cement distribution (OR, 3.009; P = 0.013), and depression (OR, 3.426; P = 0.028) were independently associated with UBPR after PVP at the early postoperative stage.
Limitations:
A further prospective controlled study is needed to explore the association between the different degrees of the aforementioned factors and UBPR after PVP.
Conclusions:
Preoperative low BMD, lumbodorsal fascial injury, multiple segment PVP, insufficient cement injected volume, unsatisfactory cement distribution, and depression were strong risk factors associated with UBPR after PVP in patients with OVCF.
Key Words:
Unsatisfactory back pain relief, residual back pain, percutaneous vertebroplasty.
Citing Articles
Safety and feasibility of a smart assistive bone-cement injection system: a cadaveric study.
Jin C, Ning M, Xu R, Ye X, Chen H, Yu J
J Orthop Surg Res. 2025; 20(1):272.
PMID: 40075404
PMC: 11905486.
DOI: 10.1186/s13018-025-05680-9.
Continuity and volume of bone cement and anti osteoporosis treatment were guarantee of good clinical outcomes for percutaneous vertebroplasty: a multicenter study.
Cheng Z, Ren G, Li Z, Gao X, Zhang D, Chen G
BMC Musculoskelet Disord. 2025; 26(1):133.
PMID: 39920627
PMC: 11806568.
DOI: 10.1186/s12891-024-08153-y.
Predicting residual pain after vertebral augmentation in vertebral compression fractures: a systematic review and critical appraisal of risk prediction models.
Wang S, Shi M, Zhou X, Yu J, Han M, Zhang X
BMC Musculoskelet Disord. 2025; 26(1):87.
PMID: 39871243
PMC: 11773721.
DOI: 10.1186/s12891-025-08338-z.
Association between vertebral bone quality score and residual back pain following percutaneous vertebroplasty for osteoporotic vertebral compression fractures.
Chen C, Wu B, Yu H, Dai Z, Yan L, Cai D
Eur Spine J. 2024; 34(2):537-545.
PMID: 39688705
DOI: 10.1007/s00586-024-08619-6.
Developing predictive models for residual back pain after percutaneous vertebral augmentation treatment for osteoporotic thoracolumbar compression fractures based on machine learning technique.
Wu H, Li C, Song J, Zhou J
J Orthop Surg Res. 2024; 19(1):803.
PMID: 39609923
PMC: 11603673.
DOI: 10.1186/s13018-024-05271-0.
Risk factors of short-term residual low back pain after PKP for the first thoracolumbar osteoporotic vertebral compression fracture.
Shen L, Yang H, Zhou F, Jiang T, Jiang Z
J Orthop Surg Res. 2024; 19(1):792.
PMID: 39587591
PMC: 11590304.
DOI: 10.1186/s13018-024-05295-6.
Percutaneous kyphoplasty combined with pediculoplasty (PKCPP) augments and internally fixates the severe osteoporotic vertebral fractures: a retrospective comparative study.
Xiao C, Wang H, Lei Y, Dai H, Zhang K, Xie M
Arch Osteoporos. 2024; 19(1):95.
PMID: 39377968
DOI: 10.1007/s11657-024-01456-6.
Incidence and prognostic factors of residual back pain in patients treated for osteoporotic vertebral compression fractures: a systematic review and meta-analysis.
Yang X, Dong Y, Liu X, Liu X, Luo H, Bao Y
Eur Spine J. 2024; 33(12):4521-4537.
PMID: 39103616
DOI: 10.1007/s00586-024-08426-z.
The Impact of Sarcopenia on the Clinical Outcomes of Percutaneous Kyphoplasty in Patients With Osteoporotic Vertebral Compression Fracture: A Retrospective Cohort Study.
Wu S, Zhong D, Zhao G, Liu Y, Ke Z, Wang Y
Geriatr Orthop Surg Rehabil. 2024; 15:21514593241261533.
PMID: 38855406
PMC: 11162599.
DOI: 10.1177/21514593241261533.
Effect of thoracolumbar fascia injury on reported outcomes after percutaneous vertebroplasty.
Yang S, Tang J, Yang Z, Jin H, Wang Q, Wang H
Front Surg. 2024; 11:1379769.
PMID: 38817944
PMC: 11137208.
DOI: 10.3389/fsurg.2024.1379769.
Clinical effects of cocktail injection on the thoracolumbar fascia injury during percutaneous vertebroplasty for osteoporotic vertebral compression fractures: a single-center, retrospective case-control study.
Liu X, Zhou Q, Sun Z, Tian J, Wang H
BMC Musculoskelet Disord. 2024; 25(1):18.
PMID: 38166954
PMC: 10759409.
DOI: 10.1186/s12891-023-07130-1.
Optimizing percutaneous vertebroplasty: extra-facet puncture for osteoporotic vertebral compression fractures.
Zheng H, Li B, Jiang Q, Jiang L, Zheng X, Jiang S
J Orthop Surg Res. 2023; 18(1):887.
PMID: 37993875
PMC: 10664349.
DOI: 10.1186/s13018-023-04368-2.
Comparison of percutaneous vertebroplasty and conservative treatment for one level thoracolumbar osteoporotic compression fracture in a 3-year study.
Xie Y, Gu H, Wei Y, Xuan A, Yu H
Sci Rep. 2023; 13(1):20264.
PMID: 37985672
PMC: 10661551.
DOI: 10.1038/s41598-023-36905-8.
Clinical outcomes with second injection after insufficient bone cement distribution in unilateral kyphoplasty for osteoporotic vertebral compressive fracture: a cohort retrospective study.
Xue Y, Zhang J, Zhang Z, Dai W, Ma C
J Orthop Surg Res. 2023; 18(1):530.
PMID: 37491307
PMC: 10369772.
DOI: 10.1186/s13018-023-03968-2.
Comparison between unilateral curved and bilateral straight percutaneous vertebral augmentation in the treatment of osteoporotic vertebral compression fractures: A meta-analysis.
Fu X, Li Y, Tian P, Xu G, Li Z
Jt Dis Relat Surg. 2023; 34(2):237-244.
PMID: 37462625
PMC: 10367155.
DOI: 10.52312/jdrs.2023.967.
Risk factors for residual back pain following percutaneous vertebral augmentation: the importance of paraspinal muscle fatty degeneration.
Gao X, Du J, Hao D, He B, Yan L
Int Orthop. 2023; 47(7):1797-1804.
PMID: 37074374
PMC: 10266997.
DOI: 10.1007/s00264-023-05809-7.
Predictors of residual low back pain in patients with osteoporotic vertebral fractures following percutaneous kyphoplasty.
Yu H, Luo G, Wang Z, Yu B, Sun T, Tang Q
Front Surg. 2023; 10:1119393.
PMID: 36816002
PMC: 9935818.
DOI: 10.3389/fsurg.2023.1119393.
[Effectiveness of unilateral percutaneous vertebroplasty for elderly osteoporotic vertebral compression fracture by different approaches with different symptom severity].
Xu H, Yang J, Liu T, He B, Chai X, Hao D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023; 37(2):168-173.
PMID: 36796811
PMC: 9970766.
DOI: 10.7507/1002-1892.202211071.
Preoperative prediction of residual back pain after vertebral augmentation for osteoporotic vertebral compression fractures: Initial application of a radiomics score based nomogram.
Ge C, Chen Z, Lin Y, Zheng Y, Cao P, Chen X
Front Endocrinol (Lausanne). 2023; 13:1093508.
PMID: 36619583
PMC: 9816386.
DOI: 10.3389/fendo.2022.1093508.
Why does patients' discharge delay after vertebral augmentation? A factor analysis of 1,442 patients.
Zhao H, Zhang Z, Wang Y, Qian B, Cao X, Yang M
Front Surg. 2022; 9:987500.
PMID: 36211299
PMC: 9538961.
DOI: 10.3389/fsurg.2022.987500.
